Gregory Kitchener
Keine laufenden Positionen mehr
Profil
Gregory Kitchener worked as a Director of Corporate Planning at Synopsys, Inc. from 2005 to 2008.
He then worked as Vice President of Finance at CEPHEID from 2008 to 2015.
After that, he worked as CFO, Chief Accounting Officer & Executive VP at BioPharmX Corp.
from 2015 to 2018.
In 2018, he became the Chief Financial Officer at Zosano Pharma Corp.
until 2020.
Kitchener holds an MBA from Cornell University and an undergraduate degree from the University of California, Santa Cruz.
Ehemalige bekannte Positionen von Gregory Kitchener
| Unternehmen | Position | Ende |
|---|---|---|
| ZOSANO PHARMA CORPORATION | Finanzdirektor/CFO | 01.02.2020 |
| TREX WIND-DOWN, INC. | Finanzdirektor/CFO | 10.10.2018 |
| CEPHEID | Corporate Officer/Principal | 01.07.2015 |
| SYNOPSYS INC. | Corporate Officer/Principal | 01.07.2008 |
Ausbildung von Gregory Kitchener
| University of California, Santa Cruz | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYNOPSYS INC. | Technology Services |
| Private Unternehmen | 3 |
|---|---|
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology CEPHEID develops, manufactures and markets fully-integrated systems that perform genetic analysis. The firm's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company was founded by Thomas L. Gutshall, William McMillan, Kurt Petersen, Greg Kovacs and M. Allen Northrup on March 4, 1996 and is headquartered in Sunnyvale, CA. | Health Technology |
BioPharmX Corp.
 BioPharmX Corp. BiotechnologyHealth Technology BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA. | Health Technology |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
